MarketInOut Stock Screener Log In | Sign Up

Recursion Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Recursion Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,409.18 mln
Float537 mln
Earnings Date11/02/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.59
Highly reliable

1-Year Forecast

7.32
Transformational upside

Relative Strength

96 / 100
Top performer

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-954%
Severely loss-making

Business Description

Recursion Pharmaceuticals is a US and UK-based drug discovery company that combines biology, chemistry, automation, and data science to find new treatments more efficiently than traditional methods allow. Founded in 2013 and headquartered in Salt Lake City, Utah, the company is currently running multiple clinical trials targeting cancers, rare genetic conditions, and blood disorders. Recursion works alongside major pharmaceutical partners including Roche, Sanofi, Bayer, and Takeda to advance its pipeline of experimental medicines.

Key Fundamentals

EPS-1.00
ROE-51.51
RPS0.11
ROIC-71.56
ROA-38.25
Interest Cover-365
EBITDA, mln-444
EV / EBITDA-4.35
EV / EBIT-3.70
Revenue, mln54.85
EV / Revenue35.19

Quote Details

Last 4.03
Change -0.21 (-4.95%)
Open 4.05
Volume 24,347,928
Turnover 98,122,152
Average Volume 30,728,158

Financial Ratios

Pre-Tax Profit Margin-954
Leverage Ratio1.33
Current Ratio5.03
Price / Book2.36
Price / Tangible Book4.59
Debt / Equity0.07
Price / Sales38.57

Financial Strength

Altman Z-Score1.3
Piotroski F-Score 4 / 9
Beneish M-Score-3.59
1-Year Target Price7.32
Short Ratio5.28
Short % of Float31.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.92% 93 / 100   
1 Month -0.98% 53 / 100   
2 Months 33.89% 96 / 100   
6 Months 18.88% 89 / 100   
1 Year -31.35% 26 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog